{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:37:31Z","timestamp":1710463051888},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,14]]},"DOI":"10.7759\/cureus.56148","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T11:59:28Z","timestamp":1710417568000},"source":"Crossref","is-referenced-by-count":0,"title":["Invasion Patterns and Long-Term Clinical Outcomes of Diffuse Tenosynovial Giant Cell Tumor of the Ankle Joint"],"prefix":"10.7759","author":[{"given":"Kumiko","family":"Yotsuya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Shido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160816","article-title":"Tenosynovial giant cell tumor: incidence, prevalence, patient characteristics, and recurrence. A registry-based cohort study in Denmark","volume":"44","author":"Ehrenstein V","year":"2017","unstructured":"Ehrenstein V, Andersen SL, Qazi I, Sankar N, Pedersen AB, Sikorski R, Acquavella JF. Tenosynovial giant cell tumor: incidence, prevalence, patient characteristics, and recurrence. A registry-based cohort study in Denmark. J Rheumatol. 2017, 44:1476-83. 10.3899\/jrheum.160816","journal-title":"J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2017.1361126","article-title":"Higher incidence rates than previously known in tenosynovial giant cell tumors","volume":"88","author":"Mastboom MJ","year":"2017","unstructured":"Mastboom MJ, Verspoor FG, Verschoor AJ, et al.. Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop. 2017, 88:688-94. 10.1080\/17453674.2017.1361126","journal-title":"Acta Orthop"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1097\/00005792-198005000-00004","article-title":"Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review","volume":"59","author":"Myers BW","year":"1980","unstructured":"Myers BW, Masi AT. Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine (Baltimore). 1980, 59:223-38.","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30100-7","article-title":"Surgical outcomes of patients with diffuse type tenosynovial giant-cell tumors: an international, retrospective, cohort study","volume":"20","author":"Mastboom MJ","year":"2019","unstructured":"Mastboom MJ, Palmerini E, Verspoor FG, et al.. Surgical outcomes of patients with diffuse type tenosynovial giant-cell tumors: an international, retrospective, cohort study. Lancet Oncol. 2019, 20:877-86. 10.1016\/S1470-2045(19)30100-7","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-013-1858-9","article-title":"Pigmented villonodular synovitis: a retrospective study of seventy five cases (eighty one joints)","volume":"37","author":"Ma X","year":"2013","unstructured":"Ma X, Shi G, Xia C, Liu H, He J, Jin W. Pigmented villonodular synovitis: a retrospective study of seventy five cases (eighty one joints). Int Orthop. 2013, 37:1165-70. 10.1007\/s00264-013-1858-9","journal-title":"Int Orthop"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.07.005","article-title":"Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature","volume":"40","author":"Ottaviani S","year":"2011","unstructured":"Ottaviani S, Ayral X, Dougados M, Gossec L. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum. 2011, 40:539-46. 10.1016\/j.semarthrit.2010.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/10711007231189491","article-title":"Outcomes of tenosynovial giant cell tumor of the foot and ankle","volume":"44","author":"Barnett JR","year":"2023","unstructured":"Barnett JR, Rudran B, Khan A, et al.. Outcomes of tenosynovial giant cell tumor of the foot and ankle. Foot Ankle Int. 2023, 44:1013-20. 10.1177\/10711007231189491","journal-title":"Foot Ankle Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.103B4.BJJ-2020-1582.R1","article-title":"Management of tenosynovial giant cell tumour of the foot and ankle","volume":"103-B","author":"Spierenburg G","year":"2021","unstructured":"Spierenburg G, Lancaster ST, van der Heijden L, et al.. Management of tenosynovial giant cell tumour of the foot and ankle. Bone Joint J. 2021, 103-B:788-94. 10.1302\/0301-620X.103B4.BJJ-2020-1582.R1","journal-title":"Bone Joint J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260795","article-title":"Treatment, recurrence rates and follow-up of tenosynovial giant cell tumor (TGCT) of the foot and ankle-a systematic review and meta-analysis","volume":"16","author":"Siegel M","year":"2021","unstructured":"Siegel M, Bode L, S\u00fcdkamp N, K\u00fchle J, Zwingmann J, Schmal H, Herget GW. Treatment, recurrence rates and follow-up of tenosynovial giant cell tumor (TGCT) of the foot and ankle-a systematic review and meta-analysis. PLoS One. 2021, 16:e0260795. 10.1371\/journal.pone.0260795","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.22038\/ABJS.2023.67493.3203","article-title":"Total synovectomy and bone grafting\/cementation after curettage of the bone lesion in diffuse\u200f type \u200fof tenosynovial\u200f giant cell tumor\u200e: a retrospective cohort study","volume":"11","author":"Jamshidi K","year":"2023","unstructured":"Jamshidi K, Sharifi Dalooei SM, Bagherifard A, Mirzaei A. Total synovectomy and bone grafting\/cementation after curettage of the bone lesion in diffuse\u200f type \u200fof tenosynovial\u200f giant cell tumor\u200e: a retrospective cohort study. Arch Bone Jt Surg. 2023, 11:342-7. 10.22038\/ABJS.2023.67493.3203","journal-title":"Arch Bone Jt Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96795-6","article-title":"Tumor location and type affect local recurrence and joint damage in tenosynovial giant cell tumor: a multi-center study","volume":"11","author":"Ota T","year":"2021","unstructured":"Ota T, Nishida Y, Ikuta K, et al.. Tumor location and type affect local recurrence and joint damage in tenosynovial giant cell tumor: a multi-center study. Sci Rep. 2021, 11:17384. 10.1038\/s41598-021-96795-6","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110730","article-title":"Osteochondral destruction in pigmented villonodular synovitis during the clinical course","volume":"39","author":"Nishida Y","year":"2012","unstructured":"Nishida Y, Tsukushi S, Nakashima H, et al.. Osteochondral destruction in pigmented villonodular synovitis during the clinical course. J Rheumatol. 2012, 39:345-51. 10.3899\/jrheum.110730","journal-title":"J Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200212000-00011","article-title":"Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee","volume":"84","author":"Chin KR","year":"2002","unstructured":"Chin KR, Barr SJ, Winalski C, Zurakowski D, Brick GW. Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee. J Bone Joint Surg Am. 2002, 84:2192-202. 10.2106\/00004623-200212000-00011","journal-title":"J Bone Joint Surg Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-009-0922-7","article-title":"Outcomes after excision of pigmented villonodular synovitis of the knee","volume":"467","author":"Sharma V","year":"2009","unstructured":"Sharma V, Cheng EY. Outcomes after excision of pigmented villonodular synovitis of the knee. Clin Orthop Relat Res. 2009, 467:2852-8. 10.1007\/s11999-009-0922-7","journal-title":"Clin Orthop Relat Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2022.11.004","article-title":"Long-term outcomes of diffuse or recurrent tenosynovial giant cell tumor treated with postoperative external beam radiation therapy","volume":"13","author":"Baniel C","year":"2023","unstructured":"Baniel C, Yoo CH, Jiang A, et al.. Long-term outcomes of diffuse or recurrent tenosynovial giant cell tumor treated with postoperative external beam radiation therapy. Pract Radiat Oncol. 2023, 13:e301-7. 10.1016\/j.prro.2022.11.004","journal-title":"Pract Radiat Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30764-0","article-title":"Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial","volume":"394","author":"Tap WD","year":"2019","unstructured":"Tap WD, Gelderblom H, Palmerini E, et al.. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. Lancet. 2019, 394:478-87. 10.1016\/S0140-6736(19)30764-0","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.820046","article-title":"Update on tenosynovial giant cell tumor, an inflammatory arthritis with neoplastic features","volume":"13","author":"Robert M","year":"2022","unstructured":"Robert M, Farese H, Miossec P. Update on tenosynovial giant cell tumor, an inflammatory arthritis with neoplastic features. Front Immunol. 2022, 13:820046. 10.3389\/fimmu.2022.820046","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/234624-invasion-patterns-and-long-term-clinical-outcomes-of-diffuse-tenosynovial-giant-cell-tumor-of-the-ankle-joint","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T11:59:31Z","timestamp":1710417571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/234624-invasion-patterns-and-long-term-clinical-outcomes-of-diffuse-tenosynovial-giant-cell-tumor-of-the-ankle-joint"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.56148","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}